Jardiance (empagliflozin), an SGLT2 inhibitor, and Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist, represent two fundamentally different approaches to treating type 2 diabetes
Self-monitoring of blood glucose plays an essential role in the prevention and management of hypoglycemia
Superior efficacy with a fixed-ratio com-bination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin-nave Japanese patients with type 2 diabetes in a phase 3, open-label, randomized trial
Make sure you do resistance training so that you lose fat without losing muscle, she says
Do I need an in-person visit first in California
These medicines are generally well tolerated, although gastrointestinal side effects are common during treatment initiation or dose escalation